Kilitch Drugs (India) Limited
The Indian Government, which previously held a 2.3 percent stake in Kilitch Drugs (India) Limited, is no longer listed among its disclosed shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting requirement.
A pharmaceutical manufacturer engaged in the production and distribution of generic drugs and pharmaceutical formulations across India. Incorporated in 1978, Kilitch Drugs operates across multiple therapeutic segments including cardiovascular, gastrointestinal, respiratory, and anti-infective treatments. The company serves hospitals, clinics, and retail pharmacy channels through its established distribution infrastructure, catering to both domestic markets and institutional healthcare providers.
The President of India holds promoter and strategic stakes on behalf of the Government of India in over 70 listed PSUs spanning oil and gas, banking, defence, mining, power and infrastructure, with aggregate market value in the tens of lakhs of crores. Disclosed stake changes typically signal divestment, OFS or strategic sale activity rather than market views, but materially impact float and price discovery in PSU stocks.